
Sutro Biopharma, Inc. is a public biotechnology company focused …
Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company. passion and purpose. Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients.
Strox - Log In
Sign in to your account. Registeration is closed.
Sutro Smart Pool Water Monitor System – Sutro, Inc
Transform your pool experience with Sutro - the innovative water monitoring solution that simplifies pool maintenance, so you can spend less time testing and more time enjoying crystal-clear water. Join thousands of satisfied customers today!
Strox - Log In
Sign in to your account. Registeration is closed.
Sutro Water Monitoring System for Pool & Spa – Sutro, Inc
It's the simple, safe, and seamless system to measure, monitor, and get treatment and chemical recommendations to keep your water safe. (1) Water test cartridge (measures and monitors pH, free chlorine (and bromine for spas), and alkalinity). It also works for saltwater pools.
Sutro Biopharma - Wikipedia
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design.
Sutro Biopharma, Inc. (STRO)
2025年3月13日 · Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience.
Sutro Biopharma Announces Strategic Portfolio Review Resulting …
2025年3月13日 · – Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as Sutro continues to seek a partner – – Three INDs for wholly-owned programs expected in the next 3 years, beginning with novel Tissue Factor ADC, STRO-004, planned for 2H 2025 – – Jane Chung, President and …
About Sutro | Sutro Biopharma, Inc.
Limitless Innovation. Breakthrough Technology. Dedicated to transforming the lives of cancer patients by creating medicines with improved therapeutic profiles for areas of unmet need.
Sutrox Sutrox - Facebook
Sutrox Sutrox is on Facebook. Join Facebook to connect with Sutrox Sutrox and others you may know. Facebook gives people the power to share and makes the world more open and connected.
- 某些结果已被删除